EGFR and non-small cell lung carcinoma: Plasma levels of HDL-C and apoa1 are up-regulated in non-small cell lung cancer patients with the epidermal growth factor receptor (EGFR) T790M mutation (NSCLC), suggesting that they have potential as markers in these patients [31].